Last 12 months
Inside the activity.
7 purchase rows · 18 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 2 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 2 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 2 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 1 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2022 Filed Mar 17, 2022 20:46 UTC |
Pietrowicz John W.Sr MD Chief Financial Officer
|
GrantCommon Stock Class A | 3,290 | $232.00 | $763,280.00 |
DisclosureSEC source: 0001156375-22-000137 · wf-form4_164754994022708.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,644 F1 · shares: Represents shares earned from a 2018 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2019-2021. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:45 UTC |
DUFFY TERRENCE ADirector · Chairman and CEO
|
Tax withholdingCommon Stock Class A | 4,638 | $232.00 | $1,076,016.00 |
DisclosureSEC source: 0001156375-22-000136 · wf-form4_164754991523869.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,138 F2 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:45 UTC |
DUFFY TERRENCE ADirector · Chairman and CEO
|
GrantCommon Stock Class A | 10,468 | $232.00 | $2,428,576.00 |
DisclosureSEC source: 0001156375-22-000136 · wf-form4_164754991523869.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,776 F1 · shares: Represents shares earned from a 2018 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2019-2021. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:45 UTC |
Tobin Jack JMD Chief Accounting Officer · MD Chief Accounting Officer
|
GrantCommon Stock Class A | 2,048 | $232.00 | $475,136.00 |
DisclosureSEC source: 0001156375-22-000135 · wf-form4_164754989005994.xml · nonDerivative · entry 3 Tobin Jack J · CIK 0001638430 · MD Chief Accounting Officer · MD Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,785 F3 · shares: On March 15, 2022, the reporting person was granted restricted shares, vesting in four equal annual installments on the first four anniversaries of the grant date, subject to the restricted share agreement. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:45 UTC |
Tobin Jack JMD Chief Accounting Officer · MD Chief Accounting Officer
|
Tax withholdingCommon Stock Class A | 73 | $232.00 | $16,936.00 |
DisclosureSEC source: 0001156375-22-000135 · wf-form4_164754989005994.xml · nonDerivative · entry 2 Tobin Jack J · CIK 0001638430 · MD Chief Accounting Officer · MD Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,737 F2 · shares: Mr. Tobin surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:45 UTC |
Tobin Jack JMD Chief Accounting Officer · MD Chief Accounting Officer
|
GrantCommon Stock Class A | 247 | $232.00 | $57,304.00 |
DisclosureSEC source: 0001156375-22-000135 · wf-form4_164754989005994.xml · nonDerivative · entry 1 Tobin Jack J · CIK 0001638430 · MD Chief Accounting Officer · MD Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,810 F1 · shares: Represents shares earned from a 2018 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2019-2021. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:44 UTC |
Vroman KenChief Transformation Officer
|
Tax withholdingCommon Stock Class A | 103 | $232.00 | $23,896.00 |
DisclosureSEC source: 0001156375-22-000133 · wf-form4_164754982632470.xml · nonDerivative · entry 2 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,309 F2 · shares: Mr. Vroman surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:44 UTC |
Vroman KenChief Transformation Officer
|
GrantCommon Stock Class A | 349 | $232.00 | $80,968.00 |
DisclosureSEC source: 0001156375-22-000133 · wf-form4_164754982632470.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,412 F1 · shares: Represents shares earned from a 2018 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2019-2021. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:43 UTC |
Cutinho SunilChief Information Officer
|
Tax withholdingCommon Stock Class A | 929 | $232.00 | $215,528.00 |
DisclosureSEC source: 0001156375-22-000132 · wf-form4_164754980447081.xml · nonDerivative · entry 2 Cutinho Sunil · CIK 0001619400 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,998 F2 · shares: Mr. Cutinho surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:43 UTC |
Cutinho SunilChief Information Officer
|
GrantCommon Stock Class A | 2,542 | $232.00 | $589,744.00 |
DisclosureSEC source: 0001156375-22-000132 · wf-form4_164754980447081.xml · nonDerivative · entry 1 Cutinho Sunil · CIK 0001619400 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,927 F1 · shares: Represents shares earned from a 2018 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2019-2021. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:43 UTC |
Sprague SuzanneSr MD Global Head of Clearing
|
GrantCommon Stock Class A | 1,020 | $232.00 | $236,640.00 |
DisclosureSEC source: 0001156375-22-000131 · wf-form4_164754978486082.xml · nonDerivative · entry 3 Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,594 F3 · shares: On March 15, 2022, the reporting person was granted restricted shares, vesting in four equal annual installments on the first four anniversaries of the grant date, subject to the restricted share agreement. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:43 UTC |
Sprague SuzanneSr MD Global Head of Clearing
|
Tax withholdingCommon Stock Class A | 66 | $232.00 | $15,312.00 |
DisclosureSEC source: 0001156375-22-000131 · wf-form4_164754978486082.xml · nonDerivative · entry 2 Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,574 F2 · shares: Ms. Sprague surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:43 UTC |
Sprague SuzanneSr MD Global Head of Clearing
|
GrantCommon Stock Class A | 222 | $232.00 | $51,504.00 |
DisclosureSEC source: 0001156375-22-000131 · wf-form4_164754978486082.xml · nonDerivative · entry 1 Sprague Suzanne · CIK 0001914409 · Sr MD Global Head of Clearing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,640 F1 · shares: Represents shares earned from a 2018 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2019-2021. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:43 UTC |
Winkler JulieSr MD Chief Commercial Officer
|
Tax withholdingCommon Stock Class A | 749 | $232.00 | $173,768.00 |
DisclosureSEC source: 0001156375-22-000130 · wf-form4_164754975701614.xml · nonDerivative · entry 2 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,850 F2 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:43 UTC |
Winkler JulieSr MD Chief Commercial Officer
|
GrantCommon Stock Class A | 2,243 | $232.00 | $520,376.00 |
DisclosureSEC source: 0001156375-22-000130 · wf-form4_164754975701614.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,599 F1 · shares: Represents shares earned from a 2018 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2019-2021. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:42 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
GiftCommon Stock Class A | 280 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-22-000129 · wf-form4_164754973256520.xml · nonDerivative · entry 3 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,466 F3 · kind: This transaction involved a gift of securities from the reporting person to a charitable organization. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:42 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
Tax withholdingCommon Stock Class A | 881 | $232.00 | $204,392.00 |
DisclosureSEC source: 0001156375-22-000129 · wf-form4_164754973256520.xml · nonDerivative · entry 2 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,746 F2 · shares: Ms. Cronin surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:42 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
GrantCommon Stock Class A | 2,542 | $232.00 | $589,744.00 |
DisclosureSEC source: 0001156375-22-000129 · wf-form4_164754973256520.xml · nonDerivative · entry 1 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,627 F1 · shares: Represents shares earned from a 2018 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2019-2021. Read SEC document |
| March 14, 2022 Filed Mar 15, 2022 00:37 UTC |
Tully SeanSr MD Global Hd Financial & OT
|
SaleCommon Stock Class A | 3,999 | $229.80 | $918,970.20 |
DisclosureSEC source: 0001156375-22-000094 · wf-form4_164730462514674.xml · nonDerivative · entry 2 Tully Sean · CIK 0001619542 · Sr MD Global Hd Financial & OT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,033 Read SEC document |
| March 14, 2022 Filed Mar 15, 2022 00:37 UTC |
Tully SeanSr MD Global Hd Financial & OT
|
SaleCommon Stock Class A | 1 | $229.81 | $229.81 |
DisclosureSEC source: 0001156375-22-000094 · wf-form4_164730462514674.xml · nonDerivative · entry 1 Tully Sean · CIK 0001619542 · Sr MD Global Hd Financial & OT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,032 Read SEC document |
| March 11, 2022 Filed Mar 11, 2022 22:35 UTC |
Tully SeanSr MD Global Hd Financial & OT
|
SaleCommon Stock Class A | 3,000 | $229.00 | $687,000.00 |
DisclosureSEC source: 0001156375-22-000092 · wf-form4_164703811168428.xml · nonDerivative · entry 1 Tully Sean · CIK 0001619542 · Sr MD Global Hd Financial & OT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,033 Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 00:41 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
GiftCommon Stock Class A | 283 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-22-000096 · wf-form4_164730485119591.xml · nonDerivative · entry 2 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,085 F2 · shares: This transaction involved a gift of securities from the reporting person to a charitable organization. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 00:41 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
SaleCommon Stock Class A | 4,000 | $227.15 | $908,612.00 |
DisclosureSEC source: 0001156375-22-000096 · wf-form4_164730485119591.xml · nonDerivative · entry 1 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,368 F1 · shares: On March 11, 2022, Ms. Cronin sold an aggregate of 4,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $227.10 to $227.264. The Company maintains a record of the transaction and copies will be provided upon request. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 15:34 UTC |
Piell Hilda HarrisSr MD & Chief HR Officer
|
SaleCommon Stock Class A | 2,000 | $244.00 | $488,000.00 |
DisclosureSEC source: 0001156375-22-000086 · wf-form4_164666726439747.xml · nonDerivative · entry 1 Piell Hilda Harris · CIK 0001409789 · Sr MD & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,440 Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 15:35 UTC |
GLICKMAN DANIEL RDirector
|
SaleCommon Stock Class A | 750 | $234.30 | $175,725.00 |
DisclosureSEC source: 0001156375-22-000080 · wf-form4_164623531791772.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,253 Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 17:25 UTC |
Piell Hilda HarrisSr MD & Chief HR Officer
|
SaleCommon Stock Class A | 1,500 | $234.01 | $351,016.20 |
DisclosureSEC source: 0001156375-22-000072 · wf-form4_164580990246169.xml · nonDerivative · entry 1 Piell Hilda Harris · CIK 0001409789 · Sr MD & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,440 Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 23:20 UTC |
Cutinho SunilSr MD & President CME Clearing
|
SaleCommon Stock Class A | 4,900 | $237.96 | $1,166,004.00 |
DisclosureSEC source: 0001156375-22-000068 · wf-form4_164496722887132.xml · nonDerivative · entry 1 Cutinho Sunil · CIK 0001619400 · Sr MD & President CME Clearing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,385 Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:41 UTC |
Carey Charles PDirector
|
SaleCommon Stock Class A | 1,500 | $244.11 | $366,166.80 |
DisclosureSEC source: 0001156375-22-000062 · wf-form4_164488928926758.xml · nonDerivative · entry 2 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 7,675 Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:41 UTC |
Carey Charles PDirector
|
SaleCommon Stock Class A | 1,500 | $244.60 | $366,905.70 |
DisclosureSEC source: 0001156375-22-000062 · wf-form4_164488928926758.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 9,175 Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 00:45 UTC |
Cook Elizabeth ADirector
|
SaleCommon Stock Class A | 1,000 | $244.25 | $244,253.80 |
DisclosureSEC source: 0001156375-22-000052 · wf-form4_164488587687464.xml · nonDerivative · entry 1 Cook Elizabeth A · CIK 0001643475 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 18,737 Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:00 UTC |
Kometer KevinSr MD Chief Information Office
|
SaleCommon Stock Class A | 6,300 | $243.44 | $1,533,649.32 |
DisclosureSEC source: 0001156375-22-000050 · wf-form4_164487240126940.xml · nonDerivative · entry 3 Kometer Kevin · CIK 0001436697 · Sr MD Chief Information Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,207 F3 · shares: On February 10, 2022, Mr. Kometer sold an aggregate of 6,300 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $242.84 to $243.84. The Company maintains a record of the transaction and copies will be provided upon request. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:00 UTC |
Kometer KevinSr MD Chief Information Office
|
SaleCommon Stock Class A | 5,057 | $244.35 | $1,235,669.35 |
DisclosureSEC source: 0001156375-22-000050 · wf-form4_164487240126940.xml · nonDerivative · entry 2 Kometer Kevin · CIK 0001436697 · Sr MD Chief Information Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,507 F2 · shares: On February 10, 2022, Mr. Kometer sold an aggregate of 5,057 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $243.85 to $244.805. The Company maintains a record of the transaction and copies will be provided upon request. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:00 UTC |
Kometer KevinSr MD Chief Information Office
|
SaleCommon Stock Class A | 2,143 | $245.07 | $525,185.01 |
DisclosureSEC source: 0001156375-22-000050 · wf-form4_164487240126940.xml · nonDerivative · entry 1 Kometer Kevin · CIK 0001436697 · Sr MD Chief Information Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,564 F1 · shares: On February 10, 2022, Mr. Kometer sold an aggregate of 2,143 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $244.87 to $245.30. The Company maintains a record of the transaction and copies will be provided upon request. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 18:00 UTC |
Dennis Michael G.Director
|
GrantCommon Stock Class A | 47 | $221.79 | $10,424.13 |
DisclosureSEC source: 0001156375-22-000040 · wf-form4_164323801022895.xml · nonDerivative · entry 1 Dennis Michael G. · CIK 0001811883 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,323.3766 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 15:21 UTC |
GERDES LARRY GDirector
|
GrantCommon Stock Class A | 75 | $221.79 | $16,634.25 |
DisclosureSEC source: 0001156375-22-000026 · wf-form4_164322844771796.xml · nonDerivative · entry 1 GERDES LARRY G · CIK 0000925105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,926.15 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 15:19 UTC |
SAVAGE TERRY LDirector
|
GrantCommon Stock Class A | 47 | $221.79 | $10,424.13 |
DisclosureSEC source: 0001156375-22-000022 · wf-form4_164322837322452.xml · nonDerivative · entry 1 SAVAGE TERRY L · CIK 0001094549 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 18,437 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 20:18 UTC |
CHOOKASZIAN DENNISDirector
|
GrantCommon Stock Class A | 47 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-22-000017 · wf-form4_164322827252386.xml · nonDerivative · entry 1 CHOOKASZIAN DENNIS · CIK 0001120026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,413 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 23:01 UTC |
Tierney Robert J JRDirector
|
GrantCommon Stock Class A | 47 | $221.79 | $10,424.13 |
DisclosureSEC source: 0001156375-22-000044 · wf-form4_164323808033231.xml · nonDerivative · entry 1 Tierney Robert J JR · CIK 0001776581 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,916 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 23:01 UTC |
Hobert William WDirector
|
GrantCommon Stock Class A | 75 | $221.79 | $16,634.25 |
DisclosureSEC source: 0001156375-22-000042 · wf-form4_164323804616839.xml · nonDerivative · entry 1 Hobert William W · CIK 0001643402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,994 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 23:01 UTC |
Cook Elizabeth ADirector
|
GrantCommon Stock Class A | 47 | $221.79 | $10,424.13 |
DisclosureSEC source: 0001156375-22-000043 · wf-form4_164323806322471.xml · nonDerivative · entry 1 Cook Elizabeth A · CIK 0001643475 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 19,737 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 23:00 UTC |
Maloney Patrick WDirector
|
GrantCommon Stock Class A | 47 | $221.79 | $10,424.13 |
DisclosureSEC source: 0001156375-22-000041 · wf-form4_164323803004299.xml · nonDerivative · entry 1 Maloney Patrick W · CIK 0001812087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,314 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 23:00 UTC |
Mulchrone Patrick JDirector
|
GrantCommon Stock Class A | 47 | $221.79 | $10,424.13 |
DisclosureSEC source: 0001156375-22-000039 · wf-form4_164323799115509.xml · nonDerivative · entry 1 Mulchrone Patrick J · CIK 0001812174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,701 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 20:23 UTC |
Carey Charles PDirector
|
GrantCommon Stock Class A | 75 | $221.79 | $16,634.25 |
DisclosureSEC source: 0001156375-22-000032 · wf-form4_164322857525506.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 4,719 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 20:22 UTC |
Lucas Deborah JDirector
|
GrantCommon Stock Class A | 47 | $221.79 | $10,424.13 |
DisclosureSEC source: 0001156375-22-000031 · wf-form4_164322855433932.xml · nonDerivative · entry 1 Lucas Deborah J · CIK 0001329150 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,604 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 20:22 UTC |
Bitsberger Timothy S.Director
|
GrantCommon Stock Class A | 47 | $221.79 | $10,424.13 |
DisclosureSEC source: 0001156375-22-000030 · wf-form4_164322853401739.xml · nonDerivative · entry 1 Bitsberger Timothy S. · CIK 0001434852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,137 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 20:22 UTC |
GLICKMAN DANIEL RDirector
|
GrantCommon Stock Class A | 47 | $221.79 | $10,424.13 |
DisclosureSEC source: 0001156375-22-000029 · wf-form4_164322851209407.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,003 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 20:21 UTC |
GEPSMAN MARTIN JDirector
|
GrantCommon Stock Class A | 47 | $221.79 | $10,424.13 |
DisclosureSEC source: 0001156375-22-000028 · wf-form4_164322848692653.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,515 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 20:21 UTC |
Kaye Daniel GDirector
|
GrantCommon Stock Class A | 47 | $221.79 | $10,424.13 |
DisclosureSEC source: 0001156375-22-000027 · wf-form4_164322846312490.xml · nonDerivative · entry 1 Kaye Daniel G · CIK 0001556974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,916 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 20:20 UTC |
Seifu RahaelDirector
|
GrantCommon Stock Class A | 47 | $221.79 | $10,424.13 |
DisclosureSEC source: 0001156375-22-000025 · wf-form4_164322843091815.xml · nonDerivative · entry 1 Seifu Rahael · CIK 0001812194 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,310 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 20:20 UTC |
SHEPARD WILLIAM RDirector
|
GrantCommon Stock Class A | 75 | $221.79 | $16,634.25 |
DisclosureSEC source: 0001156375-22-000023 · wf-form4_164322839155038.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 198,051.695 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.